UPDATE: USPTO upholds Haemonetics patent in spat with Fenwal

June 7, 2010 by MassDevice staff

The U.S. Patent and trademark office upholds the validity of a Haemonetics Corp. patent at the center of a long-running infringement spat with Fenwal Inc., even as the U.S. Court of Appeals for the Federal Circuit vacates a lower court's $15.7 million decision in favor of Haemonetics.

HAE, Fenwal logos

A federal court put the kaibosh on a lower court's decision to award $15.7 million to Haemonetics Corp. (NYSE:HAE) in a patent spat with Fenwal Inc.

Haemonetics sued Fenwal in 2005, alleging that the then-Baxter Healthcare (NYSE:BAX) subsidiary infringed a Haemonetics patent for a portable blood-collection device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.